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Although noninva-
sive means may
someday supplant
the coronary arte-
riogram as the gold
standard for defin-
ing the structural
condition of the
coronary arteries,
for the foreseeable
future the appro-
priate use of coro-
nary arteriography
as a diagnostic test
should remain.EDITOR’S PAGE
Is Coronary Arteriography a Diagnostic Test?
Several documents released recently have rekindled my interest in asking the question: is
coronary arteriography a diagnostic test? In a previous editor’s page communication, I made an
attempt to defend the diagnostic angiogram (1). I pointed out the value of the information in
addition to noninvasive risk stratification, and I emphasized the fact that true freedom of
choice for the caring physician and the patient could only be achieved once the coronary
anatomy is known. For the past 5 or more years, I have been a participant in the formation of
the new guideline for the diagnosis and management of patients with stable ischemic heart
disease. This intersocietal document provides valuable guidelines for the evaluation and
management of patients with stable ischemic heart disease with in-depth investigation of risk
assessment based on imaging modalities (2). The document differs from earlier guidelines
dealing with the subject in that the coronary anatomy is not considered as part of the baseline
information. In this document, although the coronary arteriogram is frequently referred to as
the gold standard for assessing other imaging modalities, it is not, itself, considered as one of
those. The algorithms presented direct a decision for coronary arteriography to arise from the
noninvasive imaging indicating a high likelihood of severe ischemic heart disease, or when
symptoms are unacceptable despite guideline directed medical therapy. In addition, coronary
arteriography is considered appropriate in survivors of cardiac arrest and when noninvasive
testing is inconclusive, contraindicated, or inadequate. So, one can conceive, in this hierarchical
decision-making recommendation, that coronary arteriography is considered a preamble to
revascularization rather than a diagnostic imaging modality.
I want to be clear that, as an author of this document, I find it valuable, but there will be
concern among interventional colleagues that undue restriction on coronary arteriography has been
imposed. How has coronary arteriography become relegated to a secondary or tertiary position in
the work-up of patients with stable ischemic heart disease? The answer, I believe, comes from two
directions. First, noninvasive imaging has become much more sophisticated and, if applied at the
highest level, would identify most of the patients at increased risk. Clearly the presence of ischemia,
identifiable by several noninvasive means, is a potent predictor of risk, as well as an identifier of
opportunity for improvement with revascularization strategies. The second reason is the practice of
ad hoc percutaneous coronary intervention (PCI). The recent consensus statement from the Society
for Cardiac Angiography and Interventions, “Ad Hoc Percutaneous Coronary Intervention” (3),
recognizes the widespread use of ad hoc PCI and, although providing the caution, “ad hoc PCI for
stable ischemic heart disease requires pre-procedural planning, and reassessment after diagnostic
angiography must be performed to insure its appropriateness,” it goes on to provide the 2 major
rationales: “Patients may prefer ad hoc PCI because it is convenient” and “Payers may prefer ad hoc
PCI because it is cost efficient.” Patient convenience and payer cost reduction seemed to have
carried the day since the vast majority of PCIs are now performed ad hoc.
There are a couple of other communications recently crossing our desks which may
further confound the issue. The appropriate use criteria have identified numerous scenarios
for revascularization classified as appropriate, uncertain, or inappropriate. Many of these
entail knowledge of the coronary anatomy and, therefore, coronary arteriography is a
prerequisite for classifying those indications. There seems to be wide disparity in
adherence to these appropriateness criteria. In New York State, the range of
“inappropriate” revascularization was 3% to 40% suggesting that, in addition to practice
patterns, there may be documentation issues that will have to become standardized in order to
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98have a clearer understanding of how compliant hospitals
are becoming (4). The avoidance of inappropriate
revascularization is not the only revelation that was
pointed out using the appropriate use criteria document.
A study from Ontario, Canada showed that patients
deemed appropriate for revascularization who underwent
revascularization had a 39% reduction in the composite of
death or recurrent acute coronary syndromes at 3 years
compared to patients who did not undergo
revascularization (4). In this appropriate category, patients
who did not undergo revascularization also had a mortality
rate that was more than double that of patients who did
undergo revascularization. Therefore, failing to treat these
patients with coronary revascularization increased their risk
and, even for patients who were judged to have uncertain
appropriateness, there was a trend in favor of better
outcomes with revascularization. The guidelines, which are
based on evidence as much as possible, clearly influence the
votes on the appropriate use criteria, and
these will surely influence the decision making for patients
with stable ischemic heart disease. The new guidelines
make recommendations for therapy to mitigate risk but also
recommendations for the evaluation of symptoms. The
recommendation to perform catheterization in patients with
ongoing symptoms despite guideline-directed medical
therapy importantly includes the consideration of patient
preference. Space limitations prevent further discussion of
the guidelines but I encourage you to read the document.
Perhaps in the future diagnostic coronary arteriography
may not be necessary because some form of computed
tomography angiography or other noninvasive method
may obviate the need for invasive catheterization. On the
other hand, if we look at the realities of today as reflected
by the recent report from the Cath PCI Registry of the
National Cardiovascular Data Registry (5), we see that in
2010 and 2011 among NCDR participating hospitals
there were 1,110,150 diagnostic catheterization only cases
and 941,248 percutaneous interventions. About half of
the patients with diagnostic catheterizations had a stress
test performed; however, of those, only 1.7% underwent
coronary computed tomography angiography. The
diagnostic use of the coronary arteriogram is illustrated by
the fact that, of more than a million patients undergoing
diagnostic arteriography only, one-half either had no
coronary disease or nonobstructive coronary disease.
Certainly for other imaging modalities, a negative test is
not equated with an inappropriate indication for theprocedure. Invasive imaging is viewed by some as carrying a
greater risk than noninvasive imaging, but among more than
a million diagnostic catheterizations, I noticed that the
fluoroscopy time, 5 min on average, and the contrast
volume is just over 100 cc’s. Any bleeding within 72 h was
reported in one-half of 1% of patients undergoing diagnostic
catheterization without STEMI. Virtually all diagnostic
catheterizations can be performed as outpatient procedures.
Finally, my view is that the coronary arteriogram is a
diagnostic test of value in many situations. The most
pertinent, key messages regarding revascularization in the
new guideline are, “prior to revascularization to improve
symptoms, coronary anatomy should be correlated with
functional studies to ensure lesions responsible for
symptoms are targeted,” and the new emphasis that the
degree of ischemia is a very potent predictor of cardiac
risk. When risk is high, coronary revascularization is
warranted. When symptoms persist, revascularization is
warranted. And, if revascularization is to be considered
for any patient, coronary arteriography is a requirement.
Although noninvasive means may someday supplant the
coronary arteriogram as the gold standard for defining the
structural condition of the coronary arteries, for the
foreseeable future the appropriate use of coronary
arteriography as a diagnostic test should remain.
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